Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records

Marc Casajuana, Maria Giner-Soriano, Albert Roso-Llorach, Cristina Vedia, Concepció Violan, Rosa Morros

Research output: Contribution to journalArticleResearch

2 Citations (Scopus)

Abstract

© 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Atrial fibrillation (AF) is the most common chronic arrhythmia, with increasing healthcare and economic burden and a prevalence which increases with progressive ageing. This study aims to describe overall annual costs per patient for management of non-valvular AF in a primary healthcare (PHC) setting and compare these costs between the groups of patients treated with vitamin K antagonists, antiplatelets or non-treated through a population-based study conducted with electronic health records. We analysed annual costs per person of 19,787 patients in 2012; PHC visits, hospital admissions, AF-related events requiring hospital admission, referrals to secondary specialists, sick leave, diagnostic tests and laboratory tests at PHC level, including INR determinations performed in PHC, and drug therapy. Higher costs of AF management were associated with increasing age, male sex, stroke and bleeding risks, comorbidities and occurrence of events associated to AF. The sensitivity analyses conducted showed that PHC visits and hospitalizations represented the most important part of overall costs for all patients.
Original languageEnglish
Pages (from-to)1129-1136
JournalEuropean Journal of Health Economics
Volume19
DOIs
Publication statusPublished - 1 Nov 2018

Keywords

  • Atrial fibrillation
  • Costs
  • Electronic health records
  • Haemorrhage
  • I10
  • Primary healthcare
  • Stroke

Fingerprint Dive into the research topics of 'Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records'. Together they form a unique fingerprint.

Cite this